Influenza activity in England: implications for clinical practice and laboratory referral
Published: 3 November 2026
Influenza is now circulating in the community with earlier than usual onset of activity in the 2026 to 2027 season. All eligible groups, including healthcare workers, should be encouraged to get vaccinated with the 2026 to 2027 seasonal influenza vaccine as soon as possible.
Prompt antiviral post exposure prophylaxis and treatment for seasonal influenza should be offered to eligible groups (ideally within 48 hours of exposure or symptom onset). Antivirals guidance for treatment and prophylaxis of seasonal influenza has been updated. Health professionals should familiarise themselves with the key updates, including updates to treatment recommendations for critically ill adult patients in whom treatment cannot be initiated promptly as well as updates to dosing for individuals with kidney disease.
Following relevant exposure, antiviral prophylaxis should be offered to eligible people in at-risk groups irrespective of vaccination status in light of the evidence of a drifted strain.
Laboratory specimen referral guidance has been updated for 2026 to 2027; in-season influenza referral practices now apply.
The Chief Medical Officers of the United Kingdom have published a letter to healthcare professionals. Further guidance, information and the implications for clinical practice and laboratory referral can be found on the CAS website.